<prompt> Not a part of Triple therapy immunosuppression for post-renal transplant patient is:PrednisoneCyclosporineAzathioprineBelatacept  <response>: Ans. D. BelataceptBelatacept is not part of Triple therapy immunosuppression for post-renal transplant patient. The most frequently used combination is triple therapy with- Prednisone- Calcineurin inhibitor Tacrolimus - 1st line or Cyclosporine- Antimetabolite Mycophenolate mofetil or Azathioprine Mammalian TOR mTOR inhibitors can replace one of the last two agents.Note: More recently, the U.S. Food and Drug Administration FDA approved a new co-stimulatory blocking antibody CD80 CD86, belatacept, as a new strategy to prevent long-term calcineurin inhibitor toxicity. It is indicated for prophylaxis of organ rejection in patients who are EBV seropositive and receiving a kidney transplant. 